TotalMarketCap

Rocket Pharmaceuticals

RCKTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$267.301 M

$2.44 -6.71%

Close of 6 Nov 2026

As of 6 Nov 2026, Rocket Pharmaceuticals (RCKT) has a market capitalization of $267.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$223.1M

Loss-making

Shares outstanding

109,774,597

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #223VogenxVOGX$273.8M
  2. #224Turn TherapeuticsTTRX$272.7M
  3. #225Rocket PharmaceuticalsRCKT$267.3M
  4. #226Arcturus TherapeuticsARCT$266.9M
  5. #227Cypherpunk TechnologiesCYPH$265.6M

What if Rocket Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$257,225.94

Per share 105,637× higher

Bitcoin $1.53T

$13,918.05

Per share 5,716× higher

Apple $5.02T

$45,691.65

Per share 18,765× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Rocket Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.